07/06/2025
🚨 The Great Cholesterol Scam: How Medicine Got It Wrong and Made Billions Doing It
For decades, the medical establishment pushed the theory that high cholesterol causes heart disease.
This claim became the basis for widespread statin use, lowering cholesterol levels across the population.
But mounting evidence shows the connection between cholesterol and heart disease is far weaker than believed— and that statins, despite their immense profitability, offer minimal benefits for most people while posing serious risks.
Cholesterol is essential for hormone production, brain function, and cell repair. Yet, it was vilified based on flawed studies and industry-driven guidelines.
Many studies that supported statins were sponsored by pharmaceutical companies.
Negative findings were often hidden, and cholesterol thresholds were lowered over time to label more people as “at risk,” expanding the market.
Statins were sold as life-saving, but research shows they may only extend life by a few days in high-risk patients.
They don’t reduce overall mortality in women or the elderly— two of the biggest target groups.
Side effects are common and underreported: up to 29% experience muscle pain, others face memory loss, fatigue, liver damage, and increased risk of diabetes.
There’s also emerging concern about neurological damage and testosterone suppression.
Meanwhile, the true causes of cardiovascular disease— chronic inflammation, poor metabolic health, nutrient deficiencies, and environmental toxins— have been overlooked.
The narrative focused on a lab number rather than addressing the body’s broader inflammatory and healing processes.
The trillion-dollar statin industry depends on maintaining this narrative.
But it’s time to confront the facts: cholesterol alone isn’t the enemy, and lifelong medication may not be the answer.
Real prevention starts with investigating root causes and challenging decades of dogma.